A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
Clinical trial NCT00789581 · COMPLETED
Trial details
- NCT number
- NCT00789581
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.